Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

244 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Spine and Sacroiliac Joint Involvement in Newly Diagnosed Patients With Inflammatory Bowel Disease: Clinical and MRI Findings From a Population-Based Cohort.
Vladimirova N, Møller J, Attauabi M, Madsen G, Seidelin J, Terslev L, Gosvig KK, Siebner HR, Hansen SB, Fana V, Wiell C, Bendtsen F, Burisch J, Østergaard M. Vladimirova N, et al. Among authors: burisch j. Am J Gastroenterol. 2024 Aug 20. doi: 10.14309/ajg.0000000000003039. Online ahead of print. Am J Gastroenterol. 2024. PMID: 39162769
Inflammatory bowel disease epidemiology.
Burisch J, Munkholm P. Burisch J, et al. Curr Opin Gastroenterol. 2013 Jul;29(4):357-62. doi: 10.1097/MOG.0b013e32836229fb. Curr Opin Gastroenterol. 2013. PMID: 23695429 Review.
The epidemiology of inflammatory bowel disease.
Burisch J, Munkholm P. Burisch J, et al. Scand J Gastroenterol. 2015 Aug;50(8):942-51. doi: 10.3109/00365521.2015.1014407. Epub 2015 Feb 17. Scand J Gastroenterol. 2015. PMID: 25687629 Review.
Disease activity, steroid use and extraintestinal manifestation are associated with increased disability in patients with inflammatory bowel disease using the inflammatory bowel disease disability index: a cross-sectional multicentre cohort study.
Lo B, Julsgaard M, Vester-Andersen MK, Vind I, Burisch J. Lo B, et al. Among authors: burisch j. Eur J Gastroenterol Hepatol. 2018 Oct;30(10):1130-1136. doi: 10.1097/MEG.0000000000001199. Eur J Gastroenterol Hepatol. 2018. PMID: 29979218
Disease course of inflammatory bowel disease unclassified in a European population-based inception cohort: An Epi-IBD study.
Burisch J, Zammit SC, Ellul P, Turcan S, Duricova D, Bortlik M, Andersen KW, Andersen V, Kaimakliotis IP, Fumery M, Gower-Rousseau C, Girardin G, Valpiani D, Goldis A, Brinar M, Čuković-Čavka S, Oksanen P, Collin P, Barros L, Magro F, Misra R, Arebi N, Eriksson C, Halfvarson J, Kievit HAL, Pedersen N, Kjeldsen J, Myers S, Sebastian S, Katsanos KH, Christodoulou DK, Midjord J, Nielsen KR, Kiudelis G, Kupcinskas L, Nikulina I, Belousova E, Schwartz D, Odes S, Salupere R, Carmona A, Pineda JR, Vegh Z, Lakatos PL, Langholz E, Munkholm P; Epi-IBD group. Burisch J, et al. J Gastroenterol Hepatol. 2019 Jun;34(6):996-1003. doi: 10.1111/jgh.14563. Epub 2019 Jan 21. J Gastroenterol Hepatol. 2019. PMID: 30562421
Trends in hospitalisation rates for inflammatory bowel disease in western versus newly industrialised countries: a population-based study of countries in the Organisation for Economic Co-operation and Development.
King JA, Underwood FE, Panaccione N, Quan J, Windsor JW, Kotze PG, Ng SC, Ghosh S, Lakatos PL, Jess T, Panaccione R, Seow CH, Ben-Horin S, Burisch J, Colombel JF, Loftus EV Jr, Gearry R, Halfvarson J, Kaplan GG. King JA, et al. Among authors: burisch j. Lancet Gastroenterol Hepatol. 2019 Apr;4(4):287-295. doi: 10.1016/S2468-1253(19)30013-5. Epub 2019 Feb 12. Lancet Gastroenterol Hepatol. 2019. PMID: 30765267
244 results